Abstract
Fatty liver disease is a rising problem worldwide, particularly due to metabolic syndrome. The current prevalence is 20-30%, but a further increase is expected whereby children will also be increasingly affected. The presence of fat in hepatocytes is known as steatosis or, in the case of nonalcoholic origin, nonalcoholic fatty liver (NAFL). It is basically reversible, but can progress to steatohepatitis (NASH) as an active and progressive form of fatty liver disease due to continuous cell damage. This leads to progressive liver fibrosis up to end-stage liver cirrhosis. The gold standard of diagnosis is liver biopsy, in which obesity, inflammation, and hepatocellular damage (hepatocellular ballooning) are assessed for the distinction between NAFL and NASH. The extent of fibrosis indicates the progress of the disease. Childhood and adult fatty liver diseases differ morphologically, particularly in the location and amount of fat, inflammation, and fibrosis. Alcoholic and nonalcoholic fatty liver disease/steatohepatitis cannot be reliably differentiated by histology. Clinical parameters must also be taken into consideration for the differential diagnosis of other diseases associated with fatty liver. The main therapeutic goal is to...Continue Reading
References
Mar 12, 2010·Der Pathologe·A TannapfelB Flott-Rahmel
Feb 15, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Elizabeth M BruntUNKNOWN NASH Clinical Research Network (CRN)
Mar 29, 2011·Virchows Archiv : an International Journal of Pathology·Andrea TannapfelBerenike Flott-Rahmel
Apr 27, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Arun J SanyalArthur McCullough
Jul 8, 2011·Digestive Diseases·F ScaglioniS Bellentani
Jun 19, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pierre BedossaKarine Clement
Feb 9, 2013·Der Pathologe·D GoltzH-P Fischer
Dec 4, 2013·Virchows Archiv : an International Journal of Pathology·Henning ReisHideo Andreas Baba
Apr 23, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pierre Bedossa, UNKNOWN FLIP Pathology Consortium
Jun 10, 2015·JAMA : the Journal of the American Medical Association·Mary E Rinella
Jul 15, 2015·Zeitschrift für Gastroenterologie·E RoebJ Bojunga
Aug 14, 2015·Scientific Reports·Julia KälschAli Canbay
Jan 19, 2016·Metabolism: Clinical and Experimental·Gregory Thomas Brown, David E Kleiner
Apr 8, 2016·Obesity Facts·UNKNOWN European Association for the Study of the Liver (EASL)UNKNOWN European Association for the Study of Obesity (EASO)
Jul 18, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Naga ChalasaniArun J Sanyal
Oct 29, 2017·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Emanuele Nicastro, Lorenzo D'Antiga
Dec 14, 2017·Der Pathologe·S SynorackiH A Baba
Aug 21, 2018·World Journal of Gastroenterology : WJG·Simona LeoniLuigi Bolondi
Dec 10, 2019·Lancet·Zobair M YounossiUNKNOWN REGENERATE Study Investigators
Dec 22, 2019·Journal of Hepatology·Fabio NascimbeniUNKNOWN LIDO (Liver Injury in Diabetes and Obesity) Study Group